PRESS KIT

Download the CTOAM press kit

CTOAM Press Kit: For Journalists and Members of the Press


Get Information on International Precision Oncology Company, CTOAM

DNA Strands

For press-specific information on CTOAM, please download our media kit. Here you’ll find logo downloads, company background, co-founder bios, quotes from oncogenomics expert, Alex Rolland, quotes from patients, topic ideas for journalists, and more.

Additional media content: If you’d like additional information, photos, or videos, please contact Marketing & Media or contact our Communications Coordinator at 1-833-493-5463 ext. 2.

Additional information on Precision Oncology: If you'd like more information on any of the following topics, please contact us to schedule an appointment with a member of our Precision Oncology team. Topics can include: precision oncology, genetic testing, immunotherapy, integration of precision medicine into standard care, clinical trials, the future of cancer treatment, and anything else related to cancer care.

Speaking engagements: To request one of our Precision Oncology experts to speak at your event, conference, or educational workshop, contact our Communications Coordinator.

Get Your Questions Answered!

Discover how you can get better cancer treatment

Book a free 30-min Cancer Care Strategy Session

"I can’t tell you how much your support means to me. My call today with you was invaluable. You came into our lives at the perfect time. It’s rare to just be able to talk without a sales pitch. I could tell that my needs were more important." - Diane

Discover how you can get better cancer treatment! Get your questions answered now

Book a free 30-min Cancer Care Strategy Session

Sign Up for Our Newsletter


Get the latest advancements in cancer care delivered straight to your inbox each month!

Beat cancer faster and prevent cancer recurrence

Discover the newest, leading-edge advancements in cancer care...

Read our research blog

We use cookies to enhance your experience. By continuing to visit this site, you agree to our use of cookies. More info. That's Fine